The inheritance and development of traditional Chinese medicine formulas in treating childhood asthma based on the perspective of clinical research

Abstract

IntroductionThe inheritance and development status are illustrated with research hotspots, medication patterns, and research quality based on the two literature databases of previous and recent clinical investigations of Traditional Chinese Medicine formulas in treating childhood asthma. MethodsThe relevant literature was retrieved from seven databases. Based on the year of publication, dividing the body of literature produced since the database's founding into previous and recent databases. Bibliometric, VOSviewer, IBM SPSS Modeller and modified Jadad scale were used to conduct characteristic analysis, visual analysis, herb compatibility rule analysis and research quality evaluation respectively. ResultsOne hundred and seven previous studies and 212 recent studies were included. The outcome indicators are inherited symptoms and syndrome, and develop into mechanistic indicators such as pulmonary function. The common herbs are Glycyrrhiza uralensis Fisch., Ephedra sinica Stapf and Prunus armeniaca L.var.ansu Maxim., and the development of Schisandra chinensis (Turcz.) Baill., Astragalus membranaceus (Fisch.) Bge.var. mongholicus (Bge.) Hsiao and Poria cocos (Schw.) Wolf are increasing. The compatibility of herbs inherited the combination of E. sinica Stapf and G. uralensis Fisch. based on the development of Asarum heterotropoides Fr. Schmidt var. mandshuricum (Maxim.) Kitag., S. chinensis (Turcz.) Baill. and Pinellia ternata (Thunb.) Breit. The research quality has been improved. ConclusionFrom the clinical research perspective, the study of Traditional Chinese Medicine formulas for the treatment of childhood asthma has its own unique inheritace and development, covering a number of areas.